ATF6B expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.667000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.291620E-01
Normal-vs-Stage2
2.319800E-01
Normal-vs-Stage3
2.157400E-01
Normal-vs-Stage4
7.156400E-01
Stage1-vs-Stage2
8.015400E-01
Stage1-vs-Stage3
4.984000E-01
Stage1-vs-Stage4
1.996590E-01
Stage2-vs-Stage3
3.796400E-01
Stage2-vs-Stage4
3.877400E-01
Stage3-vs-Stage4
2.368400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.653200E-01
Normal-vs-AfricanAmerican
5.794500E-02
Normal-vs-Asian
4.419400E-01
Caucasian-vs-AfricanAmerican
1.020960E-01
Caucasian-vs-Asian
9.615800E-01
AfricanAmerican-vs-Asian
5.164200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.231600E-01
Normal-vs-Female
2.126000E-01
Male-vs-Female
8.723200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.696800E-01
Normal-vs-Age(41-60Yrs)
1.823590E-01
Normal-vs-Age(61-80Yrs)
2.767800E-01
Normal-vs-Age(81-100Yrs)
7.018400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.539800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.244400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.814600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.770800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.908600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.068000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.014200E-01
Normal-vs-Daily Drinker
7.073700E-02
Normal-vs-Weekly Drinker
2.465400E-01
Normal-vs-Occasional Drinker
7.808600E-01
Normal-vs-Social Drinker
7.089700E-02
Non Drinker-vs-Daily Drinker
1.671950E-01
Non Drinker-vs-Weekly Drinker
6.528600E-01
Non Drinker-vs-Occasional Drinker
2.102000E-01
Non Drinker-vs-Social Drinker
4.530600E-01
Daily Drinker-vs-Weekly Drinker
4.298400E-01
Daily Drinker-vs-Occasional Drinker
6.961100E-03
Daily Drinker-vs-Social Drinker
4.131200E-01
Weekly Drinker-vs-Occasional Drinker
1.092000E-01
Weekly Drinker-vs-Social Drinker
9.030600E-01
Occasional Drinker-vs-Social Drinker
4.176400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.204000E-02
Normal-vs-Grade 2
1.867740E-02
Normal-vs-Grade 3
1.333620E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.082900E-03
Grade 1-vs-Grade 3
3.017500E-03
Grade 1-vs-Grade 4
8.204000E-02
Grade 2-vs-Grade 3
5.275800E-01
Grade 2-vs-Grade 4
1.867740E-02
Grade 3-vs-Grade 4
1.333620E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.909370E-01
Normal-vs-NonDiabetic
2.877200E-01
Diabetic-vs-NonDiabetic
3.663800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.720500E-02
Normal-vs-NoPancreatitis
3.025800E-01
Pancreatitis-vs-NoPancreatitis
5.629400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.118400E-01
Normal-vs-N1
1.801610E-01
N0-vs-N1
9.641600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.043600E-01
Normal-vs-TP53-NonMutant
3.380000E-01
TP53-Mutant-vs-TP53-NonMutant
9.177600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
